Skip to main navigation Skip to search Skip to main content

Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial

  • Kim A. Connelly
  • , C. David Mazer
  • , Pankaj Puar
  • , Hwee Teoh
  • , Chao Hung Wang
  • , Tamique Mason
  • , Farhad Akhavein
  • , Ching Wen Chang
  • , Min Hui Liu
  • , Ning I. Yang
  • , Wei Siang Chen
  • , Yu Hsiang Juan
  • , Erika Opingari
  • , Yaseen Salyani
  • , William Barbour
  • , Aryan Pasricha
  • , Shamon Ahmed
  • , Andrew Kosmopoulos
  • , Raj Verma
  • , Michael Moroney
    • Ehab Bakbak, Aishwarya Krishnaraj, Deepak L. Bhatt, Javed Butler, Mikhail N. Kosiborod, Carolyn S.P. Lam, David A. Hess, Otavio Rizzi Coelho-Filho, Myriam Lafreniere-Roula, Kevin E. Thorpe, Adrian Quan, Lawrence A. Leiter, Andrew T. Yan, Subodh Verma

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science